Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 20,02120,040 of 20,252 grants

Completed NON-SBIR/STTR RPGS
Ceramide-Rich Platforms Functionalize Gemcitabine Uptake
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2021 – 2025

Our data indicate that in select settings activation of acid sphingomyelinase (ASMase)/ceramide signaling in tumor endothelial cells by radiation and certain chemotherapies synergi...

$4.05M
USD
Completed NON-SBIR/STTR RPGS
Early Detection and Diagnosis of Lung Cancer with Endomicroscopy
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2021 – 2025

PROJECT SUMMARY Early diagnosis of lung cancer is critical to patient survival.Unfortunately the vast majority of cases are detected once symptoms arise and the cancer has spread o...

$6.62M
USD
Completed NON-SBIR/STTR RPGS
Translating Hyperpolarized 13C Metabolic MRI to Predict Renal Tumor Aggressiveness
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2021 – 2025

Project summary: This project aims to clinically translate hyperpolarized (HP) 13C pyruvate MRI as an innovative metabolic imaging approach for noninvasive prediction of renal tumo...

$5.99M
USD
Completed NON-SBIR/STTR RPGS
Using natural language processing to determine predictors of healthy diet and physical activity behavior change in ovarian cancer survivors
NATIONAL CANCER INSTITUTE University of Arizona United States 2021 – 2021

ABSTRACT Cancer survivors are a growing population in the United States; more than 16 million currently live in the US and by 2030 this number is expected to exceed 22 million.It i...

$2.09M
USD
Completed NON-SBIR/STTR RPGS
Eradication of Escaped Variant Tumor Cells for Cancer Immunotherapy
NATIONAL CANCER INSTITUTE Wake Forest University Health Sciences United States 2021 – 2025

Project Summary Recently, we discovered that adoptive transfer of CD39KO tumor-specific (mixed CD4+ and CD8+) T cells, resulted in long-term survival of mice bearing large establis...

$3.74M
USD
Completed OTHER RESEARCH-RELATED
Emerging Cell Therapies: Realizing the Vision of NextGen Cell Therapeutics
NATIONAL CANCER INSTITUTE Keystone Symposia United States 2021 – 2021

ABSTRACT Support is requested for a Keystone Symposia conference entitled Emerging Cell Therapies: Realizing the Vision of NextGen Smart Cell Therapeutics for Disease organized by...

$40K
USD
Completed NON-SBIR/STTR RPGS
Impact of brain estrogens on cognition and brain aging in a non-human primate
NATIONAL CANCER INSTITUTE University of Massachusetts Amherst United States 2021 – 2025

SUMMARY Aromatase inhibitors (AIs) are drugs that inhibit estrogen synthesis and that are prescribed to prevent the recurrence of estrogen responsive breast cancers.However, AIs, s...

$5.63M
USD
Completed NON-SBIR/STTR RPGS
New Statistical Methods for Modelling Cancer Outcomes
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2021 – 2024

PROJECT SUMMARY/ABSTRACT Lung cancer is one of the most common causes of mortality worldwide. Radiomic features have been shown to provide prognostic values in predicting lung canc...

$3.65M
USD
Completed NON-SBIR/STTR RPGS
A Leukemia Cell-Specific Coiled-Coil Protein for Treatment of Chronic Myeloid Leukemia
NATIONAL CANCER INSTITUTE University of Utah United States 2021 – 2025

Project Summary/Abstract The long-term goals of this proposal are to explore the protein dimerization interface as an area for therapeutic intervention.Protein dimerization/oligome...

$3.49M
USD
Completed NON-SBIR/STTR RPGS
DEHART: Dose-Escalated Hypofractionated Adaptive Radiation Therapy for Head and Neck Cancers
NATIONAL CANCER INSTITUTE Medical College of Wisconsin United States 2021 – 2022

Abstract Locoregional failure remains the principal mode of mortality in head and neck squamous cell carcinomas (HNSCCs) treated with conventional chemoradiation therapy over 7 wee...

$2.02M
USD
Completed NON-SBIR/STTR RPGS
Re-engineered Mitochondrially Targeted p53 Gene Therapy in Liver Cancer
NATIONAL CANCER INSTITUTE University of Utah United States 2021 – 2022

Abstract: Hepatocellular carcinoma (HCC), the most common cancer of the liver, is the third leading cause of cancer death worldwide. In the U.S., the overall 5-year survival rate f...

$1.78M
USD
Completed NON-SBIR/STTR RPGS
ROS Targeted Therapy for Lethal Prostate Cancer
NATIONAL CANCER INSTITUTE Cedars-Sinai Medical Center United States 2021 – 2022

PROJECT SUMMARY Prostate cancer (PC) is the second leading cause of cancer mortality in American men.Current therapeutics only show marginal efficacy and are often associated with...

$1.95M
USD
Completed NON-SBIR/STTR RPGS
Inhibition of CaMKK2 sensitizes rectal cancers to radiation therapy
NATIONAL CANCER INSTITUTE Duke University United States 2021 – 2022

Abstract In the United States, colon cancer and rectal cancer are the third most common cancer diagnosed in both men and women.The standard of care for stage II-III rectal cancer i...

$1.88M
USD
Completed TRAINING, INDIVIDUAL
Characterizing the effects of cis-regulatory variation on patient outcomes and treatment response in Multiple Myeloma
NATIONAL CANCER INSTITUTE Translational Genomics Research Inst United States 2021 – 2023

ABSTRACT Multiple Myeloma (MM) is a malignancy of plasma cells and the second most common hematological cancer accounting for 2% of cancer deaths. MM is associated with a poor prog...

$592.5K
USD
Completed TRAINING, INDIVIDUAL
Elucidating Oncogenic Mechanisms Underlying Wilms Tumor Using Kidney Organoids
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2021 – 2023

PROJECT SUMMARY/ABSTRACT Wilms tumor is the most common pediatric kidney cancer. Blastemal-predominant tumors are classified as high-risk and have demonstrated resistance to chemot...

$392K
USD
Completed TRAINING, INDIVIDUAL
Exploiting convergent evolution to design biomarker extraction tools for the prediction of therapeutic response in cancer
NATIONAL CANCER INSTITUTE Case Western Reserve University United States 2021 – 2024

PROJECT SUMMARY/ABSTRACT The effective treatment of drug resistant tumors represents one of the greatest unmet needs in oncology research. The evolution of therapeutic resistance i...

$526.9K
USD
Completed NON-SBIR/STTR RPGS
Ceramide-Rich Platforms Functionalize Gemcitabine Uptake
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2021 – 2025

Our data indicate that in select settings activation of acid sphingomyelinase (ASMase)/ceramide signaling in tumor endothelial cells by radiation and certain chemotherapies synergi...

$3.97M
USD
Completed NON-SBIR/STTR RPGS
A Leukemia Cell-Specific Coiled-Coil Protein for Treatment of Chronic Myeloid Leukemia
NATIONAL CANCER INSTITUTE University of Utah United States 2021 – 2025

Project Summary/Abstract The long-term goals of this proposal are to explore the protein dimerization interface as an area for therapeutic intervention. Protein dimerization/oligom...

$3.42M
USD
Completed NON-SBIR/STTR RPGS
Translating Hyperpolarized 13C Metabolic MRI to Predict Renal Tumor Aggressiveness
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2021 – 2025

Project summary: This project aims to clinically translate hyperpolarized (HP) 13C pyruvate MRI as an innovative metabolic imaging approach for noninvasive prediction of renal tumo...

$6.22M
USD
Completed NON-SBIR/STTR RPGS
Novel small molecule USP7 Inhibitors for p53 activation and cancer therapy
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2021 – 2025

Project Summary: The long-term objective of this project is to develop a novel targeted therapy for human cancers by reactivating the tumor suppression pathways. Although p53 is fr...

$3.63M
USD